Trial Search Results

Tissue Sealant Use in LASIK Enhancement Surgery

The purpose of the study is to evaluate the use of prophylactic tissue sealant to prevent epithelial ingrowth from gaining access under a LASIK flap with repeat LASIK surgery

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Drug: Tissue sealant


Phase 4


Inclusion Criteria:

   - Subjects age 21 and older

   - Subjects with healthy eyes

   - Subjects who have previously undergone LASIK surgery

   - Subjects with residual refractive error.

Exclusion Criteria:

   - Subjects under the age of 21.

   - Subjects with excessively thin corneas.

   - Subjects with topographic evidence of keratoconus.

   - Subjects with ectatic eye disorders.

   - Subjects with autoimmune diseases.

   - Subjects who are pregnant or nursing.

Ages Eligible for Study

21 Years - 99 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Edward E Manche, MD